Berberine exerts its anticancer activity against A549 and H1299 lung cancer cell lines by promoting Bcl-2-associated X protein (Bax) and caspase-3 Bcl-2-associated X protein (Bax) and caspase-3-mediated apoptosis [176]. The gene discussed is BAX; the disease is lung carcinoma.